Center for Immunotherapy and Cell-Based Technologies

Novosibirsk — Kaliningrad — Moscow — Irkutsk
Main

Prostate cancer

Xenovaccinotherapy for cancer

http://www.medicalnewstoday.com/rss/cancer-oncology.xmlhttp://www.medicalnewstoday.com/rss/immune_system.xmlhttp://www.medicalnewstoday.com/rss/multiple_sclerosis.xmlhttp://www.medicalnewstoday.com/rss/stem_cell_research.xml

  • docid_1233.pageCache.php

17.09.2019 Testing for circulating tumor cells in the blood alongside PSA can increase accuracy of prostate cancer diagnosis to more than 90%, new study reveals....

12.09.2019 A new study concludes that men who regularly eat mushrooms have a lower risk of developing prostate cancer than those who rarely eat mushrooms....

25.07.2019 Scientists investigated the microbiome of prostate fluid and found differences between people with prostate cancer and people without the condition....

18.03.2019 Coffee is a complex cocktail of compounds. A recent study identifies two particular molecules that might have cancer-fighting capabilities....

18.02.2019 Lupron (leuprolide acetate) is a type of hormone therapy for people with prostate cancer. Lupron is an injection drug, and doctors often prescribe it ...

09.02.2019 New research in mice finds that fatty acids fuel prostate tumor growth and that blocking the uptake of fatty acids slows cancer progression....

27.12.2018 A newly developed test can detect the risk of metastasis in people with prostate cancer at a quicker rate, lower cost, and using smaller tissue sample...

23.12.2018 By coating nanoparticles with gold, researchers have successfully destroyed prostate cancer cells in people without damaging surrounding tissue....

11.12.2018 Back pain is a common complaint with many possible causes. In some cases, chronic, unexplained back pain can occur with advanced prostate cancer. Lear...

06.12.2018 A prostatectomy is one treatment option for prostate cancer. It involves the surgical removal of the prostate gland. Following a prostatectomy, doctor...


Immunotherapy for cancer

An active specific immunotherapy (vaccinotherapy) is a strategy using tumor-associated antigens for including antitumor immune responses. The small structural distinctions of the xenogenic tumor-associated antigens from their human analogues render these antigens highly immunogenic and capable of including immune-mediated, antitumor responses in a patient not only at early, but also at advanced stages of disease, when tumor-derived immunosuppression is significant. Tumor-specfic immunotherapy is able to generate a selective and long-term antitumor effect. Such a therapy has no complications attributable to chemotherapy.

Xenovaccinotherapy for cancer